Felix Barron , PA-C
Physician Assistant • El Paso, TX
11410 Vista Del Sol Dr Ste A
El Paso, TX 799365332
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on December 13, 2011; this date does not establish years in practice.
-
Published CMS data list 1,547 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levocetirizine Dihydrochloride — 248 prescription fills, including refills.
- Montelukast Sodium — 184 prescription fills, including refills.
- Desloratadine — 129 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 32 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 75% of clinicians listed under Physician Assistant in El Paso, TX (2024, 80 clinicians with data). Median for this group: 413. Middle half: 88 to 1,363.
More Part D prescriptions than 80% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: 261. Middle half: 73 to 938.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,421 in 2020 to 1,547 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
11410 Vista Del Sol Dr Ste A
El Paso, TX 799365332
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,314 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$857,738 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,469.51 across 77 records.
By nature of payment
- Food and Beverage: $2,323.85 across 74 records.
- Education: $145.66 across 3 records.
Reporting-company totals (3 largest of 16)
- AstraZeneca Pharmaceuticals LP: $498.43 across 7 records.
- Regeneron Pharmaceuticals, Inc.: $242.27 across 7 records.
- Incyte Corporation: $202.01 across 12 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in El Paso and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Physician Assistant in El Paso, TX (2024, 80 clinicians with data). Median for this group: 413. Middle half: 88 to 1,363.
More Part D prescriptions than 80% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: 261. Middle half: 73 to 938.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in El Paso, TX (2024, 80 clinicians with data). Median for this group: $12,939. Middle half: $825 to $169,982.
A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: $7,999. Middle half: $749 to $103,240.
161 active clinicians are listed under Physician Assistant with a practice address in El Paso, TX (11,008 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in El Paso
6.2% of these 161 clinicians have the CMS telehealth indicator.
41.6% of these 161 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,421 in 2020 and 1,547 in 2024.
- 2020: 1,421
- 2021: 1,572
- 2022: 1,595
- 2023: 1,453
- 2024: 1,547
-
30-day fills
30-day fills increased 18% from 1,966 in 2020 to 2,314 in 2024.
- 2020: 1,966
- 2021: 2,325
- 2022: 2,393
- 2023: 2,275
- 2024: 2,314
-
Part D drug cost
Part D drug cost increased 870% from $88,414 in 2020 to $857,738 in 2024.
- 2020: $88,414
- 2021: $106,333
- 2022: $1,501,846
- 2023: $1,053,895
- 2024: $857,738
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $858.49 in 2021 to $2,469.51 in 2025.
- 2021: $858.49
- 2022: $1,923.25
- 2023: $1,542.67
- 2024: $900.78
- 2025: $2,469.51
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 77 records totaling $2,469.51.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $138.19 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $124.99 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $121.83 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $112.68 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $108.56 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $104.43 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $104.08 |
| Sanofi and Genzyme US Companies |
Education
In-kind items and services
|
DUPIXENT | General | $99.95 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $99.75 |
| Ionis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DAWNZERA | General | $37.86 |
| Amgen Inc. |
Education
In-kind items and services
|
— | General | $34.00 |
| BioCryst Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ORLADEYO | General | $32.93 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.67 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Hizentra | General | $31.18 |
| BioCryst Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ORLADEYO | General | $30.80 |
| Ionis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $28.53 |
| Pharming Healthcare, Inc. |
Food and Beverage
In-kind items and services
|
RUCONEST | General | $28.53 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $28.06 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
XOLAIR | General | $27.86 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $27.83 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.76 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.75 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.64 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $27.23 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Andembry | General | $26.55 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 248 | 14,478 | $3,047.02 | 83 |
| Montelukast Sodium | Montelukast Sodium | 184 | 10,950 | $1,479.79 | 66 |
| Desloratadine | Desloratadine | 129 | 5,712 | $4,928.52 | 38 |
| Fluticasone Propionate | Fluticasone Propionate | 121 | 6,660 | $2,006.86 | 51 |
| Prednisone | Prednisone | 118 | 647 | $202.90 | 88 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 105 | 2,517 | $3,337.82 | 50 |
| Azelastine Hcl | Azelastine Hcl | 76 | 4,218 | $2,803.18 | 39 |
| Azithromycin | Azithromycin | 67 | 335 | $276.58 | 53 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 58 | 2,099 | $960.43 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 55 | 1,830 | $906.28 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 983 | $452.15 | 18 |
| Cefuroxime | Cefuroxime Axetil | 35 | 354 | $634.26 | 30 |
| Levofloxacin | Levofloxacin | 24 | 240 | $64.97 | 18 |
| Haegarda | C1 Esterase Inhibitor | 24 | 672 | $775,907.34 | — |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | 930 | $18,714.20 | 11 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 23 | 930 | $17,949.52 | — |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | 630 | $1,821.08 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | 606 | $4,641.26 | — |
| Carbinoxamine Maleate | Carbinoxamine Maleate | 18 | 900 | $778.35 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | 480 | $8,239.88 | — |
| Famotidine | Famotidine | 15 | 870 | $188.59 | — |
| Mometasone Furoate | Mometasone Furoate | 14 | 940 | $2,225.63 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 138 | $127.02 | 11 |
| Mupirocin | Mupirocin | 13 | 388 | $130.62 | — |
| Ipratropium Bromide | Ipratropium Bromide | 13 | 398 | $400.30 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant
Physician Assistant
Physician Assistant (Certified)
Allergy & Immunology - Allergy
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated December 13, 2011.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Physician Assistants in El Paso
- Mireya Lomeli, PA
- Jessica Romero, PA-C
- Lori Berumen, PA-C
- Javier Martinez, PHYSICIAN ASSISTANT
- Irish Faye Pugao, PA
- Miriam Munoz, PA
Mailing Address
11410 Vista Del Sol Dr Ste A
El Paso, TX 799365332
Phone: 9155926269